Copy-back viral genomes induce a cellular stress response that interferes with viral protein expression without affecting antiviral immunity.


Journal

PLoS biology
ISSN: 1545-7885
Titre abrégé: PLoS Biol
Pays: United States
ID NLM: 101183755

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 14 07 2023
accepted: 15 10 2023
revised: 04 12 2023
medline: 6 12 2023
pubmed: 20 11 2023
entrez: 20 11 2023
Statut: epublish

Résumé

Antiviral responses are often accompanied by translation inhibition and formation of stress granules (SGs) in infected cells. However, the triggers for these processes and their role during infection remain subjects of active investigation. Copy-back viral genomes (cbVGs) are the primary inducers of the mitochondrial antiviral signaling (MAVS) pathway and antiviral immunity during Sendai virus (SeV) and respiratory syncytial virus (RSV) infections. The relationship between cbVGs and cellular stress during viral infections is unknown. Here, we show that SGs form during infections containing high levels of cbVGs, and not during infections with low levels of cbVGs. Moreover, using RNA fluorescent in situ hybridization to differentiate accumulation of standard viral genomes from cbVGs at a single-cell level during infection, we show that SGs form exclusively in cells that accumulate high levels of cbVGs. Protein kinase R (PKR) activation is increased during high cbVG infections and, as expected, is necessary for virus-induced SGs. However, SGs form independent of MAVS signaling, demonstrating that cbVGs induce antiviral immunity and SG formation through 2 independent mechanisms. Furthermore, we show that translation inhibition and SG formation do not affect the overall expression of interferon and interferon stimulated genes during infection, making the stress response dispensable for global antiviral immunity. Using live-cell imaging, we show that SG formation is highly dynamic and correlates with a drastic reduction of viral protein expression even in cells infected for several days. Through analysis of active protein translation at a single-cell level, we show that infected cells that form SGs show inhibition of protein translation. Together, our data reveal a new cbVG-driven mechanism of viral interference where cbVGs induce PKR-mediated translation inhibition and SG formation, leading to a reduction in viral protein expression without altering overall antiviral immunity.

Identifiants

pubmed: 37983241
doi: 10.1371/journal.pbio.3002381
pii: PBIOLOGY-D-23-01775
pmc: PMC10695362
doi:

Substances chimiques

Viral Proteins 0
Interferons 9008-11-1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e3002381

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI134862
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI137062
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

Copyright: © 2023 González Aparicio et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

mBio. 2015 Oct 06;6(5):e01265-15
pubmed: 26443454
PLoS Pathog. 2015 Sep 03;11(9):e1005122
pubmed: 26336095
Nat Rev Immunol. 2017 Oct;17(10):647-660
pubmed: 28669985
Mol Cells. 2018 Mar 31;41(3):214-223
pubmed: 29463066
PLoS Pathog. 2014 Mar 20;10(3):e1004012
pubmed: 24651521
J Virol. 2014 Jan;88(1):456-68
pubmed: 24155404
J Biol Chem. 2005 Apr 29;280(17):16925-33
pubmed: 15684421
Mol Cell. 2019 Sep 19;75(6):1203-1217.e5
pubmed: 31494035
Science. 2014 Jan 3;343(6166):84-87
pubmed: 24336571
J Biol Chem. 2020 Feb 7;295(6):1426-1438
pubmed: 31896577
Cell Host Microbe. 2012 Jul 19;12(1):71-85
pubmed: 22817989
Microbiol Mol Biol Rev. 2022 Sep 21;86(3):e0008621
pubmed: 35658541
J Virol. 2010 Dec;84(23):12274-84
pubmed: 20844027
J Biol Chem. 2020 Dec 18;295(51):17672-17683
pubmed: 33454006
PLoS Pathog. 2022 Nov 1;18(11):e1010930
pubmed: 36318584
J Biol Chem. 2019 Apr 19;294(16):6430-6438
pubmed: 30804210
J Gen Virol. 2012 Feb;93(Pt 2):267-274
pubmed: 21994324
J Mol Biol. 2009 Jul 10;390(2):319-38
pubmed: 19445956
Virology. 2011 Apr 25;413(1):103-10
pubmed: 21377708
J Virol. 2011 Dec;85(23):12442-54
pubmed: 21957303
Nat Commun. 2017 Oct 6;8(1):799
pubmed: 28986577
J Virol. 2019 Feb 5;93(4):
pubmed: 30463965
Mol Cell. 2023 Apr 6;83(7):1180-1196.e8
pubmed: 37028415
Genes Cells. 2013 Feb;18(2):135-46
pubmed: 23279204
Biochemistry. 2018 May 1;57(17):2488-2498
pubmed: 29595960
Bio Protoc. 2016 May 20;6(10):
pubmed: 30079370
PLoS Pathog. 2009 Jun;5(6):e1000473
pubmed: 19521506
PLoS One. 2016 Aug 25;11(8):e0161793
pubmed: 27560627
Nat Methods. 2014 Aug;11(8):783-784
pubmed: 25075903
J Virol. 2020 Jun 16;94(13):
pubmed: 32295917
PLoS Pathog. 2013 Oct;9(10):e1003703
pubmed: 24204261
Viruses. 2020 Sep 04;12(9):
pubmed: 32899736
Nat Microbiol. 2021 May;6(5):672-681
pubmed: 33795879
Methods Enzymol. 2007;431:61-81
pubmed: 17923231
N Engl J Med. 2005 Apr 28;352(17):1749-59
pubmed: 15858184
Bio Protoc. 2018 Jan 5;8(1):
pubmed: 29552591
PLoS Pathog. 2016 Feb 10;12(2):e1005444
pubmed: 26862753
J Immunol. 2006 Oct 1;177(7):4503-13
pubmed: 16982887
J Virol. 2018 Jul 31;92(16):
pubmed: 29875241
J Virol. 2010 Oct;84(20):10457-66
pubmed: 20631127
Mol Cell. 2019 Mar 7;73(5):946-958.e7
pubmed: 30661979
Lancet Glob Health. 2021 Aug;9(8):e1077-e1087
pubmed: 34166626
PLoS One. 2012;7(8):e43031
pubmed: 22912779
FASEB J. 2017 Apr;31(4):1337-1353
pubmed: 28011649
Nat Microbiol. 2019 Jul;4(7):1075-1087
pubmed: 31160826
J Immunol. 2008 Apr 1;180(7):4910-8
pubmed: 18354215
mBio. 2020 Aug 25;11(4):
pubmed: 32843550

Auteurs

Lavinia J González Aparicio (LJ)

Department of Molecular Microbiology and Center for Women Infectious Disease Research, Washington University School of Medicine in St. Louis, Missouri, United States of America.

Yanling Yang (Y)

Department of Molecular Microbiology and Center for Women Infectious Disease Research, Washington University School of Medicine in St. Louis, Missouri, United States of America.

Matthew Hackbart (M)

Department of Molecular Microbiology and Center for Women Infectious Disease Research, Washington University School of Medicine in St. Louis, Missouri, United States of America.

Carolina B López (CB)

Department of Molecular Microbiology and Center for Women Infectious Disease Research, Washington University School of Medicine in St. Louis, Missouri, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH